ONCY
Oncolytics Biotech
ONCY
ONCY
33 hedge funds and large institutions have $1.38M invested in Oncolytics Biotech in 2023 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 12 increasing their positions, 4 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
Holders
33
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$276K | |
| 2 | +$60.7K | |
| 3 | +$20.7K | |
| 4 |
SS
Simplicity Solutions
Minneapolis,
Minnesota
|
+$13.9K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$12.3K |
Top Sellers
| 1 | -$42K | |
| 2 | -$41K | |
| 3 | -$32.8K | |
| 4 |
Stifel Financial
St. Louis,
Missouri
|
-$25.9K |
| 5 |
Rockefeller Capital Management
New York
|
-$9K |